Novus Comms November 2025 #newsletter covering ✅ Research Talks Nov 2nd, 9th & 16th StockBox Media covering #CINH #MANO #80M #ZOO #KDNC #PALM #TRI #AAI #URU #CMR #OHGR #MPAL. Ultimate Breakout podcasts Nov30th covering #URU #KDNC #MDH #SBDS + RNS #HVO #POLB #ELEG Read: https://mailchi.mp/branduk/novus-comms-november-2025-monthly-newsletter
Continue readinghVIVO plc (AIM: HVO), a full-service early phase Contract Research Organisation (CRO) and the world leader in human challenge clinical trials, announces its German subsidiary CRS, has signed contracts worth over £5 million since September. The early-phase clinical trial service contracts have been signed with five clients, including two returning mid-sized German pharma customers reaffirming CRS’ strong reputation and long-standing relationships in Germany. These pharma partnerships, given their volume and consistency, strengthens the Group’s sales pipeline…
Continue readinghVIVO plc (AIM: HVO), a full-service early phase Contract Research Organisation (CRO) and the world leader in human challenge clinical trials, announces key insights from its scientific presentations at the 10th European Scientific Working Group on Influenza (“ESWI”) Conference in Valencia, and the World Vaccine Congress Europe in Amsterdam, which both took place in October 2025. hVIVO presented positive data from a number of newly developed human challenge models reinforcing hVIVO’s continued world-leading capabilities in accelerating…
Continue readinghVIVO plc (AIM: HVO), a full-service early phase Contract Research Organisation (CRO) and the world leader in human challenge clinical trials, announces that Yamin ‘Mo’ Khan, Chief Executive Officer, will be presenting in-person at the Jefferies Global Healthcare Conference in London on 20 November 2025 at 12.30pm GMT. Alongside the presentation, the Company will also be available for one-to-one meetings. The Jefferies Global Healthcare Conference is the largest healthcare-dedicated conference in Europe and is taking place between…
Continue readingNovus Comms September 2025 newsletter covering ✅ StockBox Media Research Talks September 7th | September 14th | September 21st covering #MANO #PALM #MOS #BUX #GRX #KDNC #CGNR #ECR #PSY #TRU. Breakout Capital Ventures podcast features Alan Green covering #MDH, #KDNC and #HAMA plus #HVO, #EGT & #POLB updates plus CEO interviews with #KDNC Cadence Minerals Read: https://mailchi.mp/branduk/novus-comms-september-2025-monthly-newsletter
Continue readingNovus Communications June 2025 #newsletter covering European Green Transition #EGT announcements & interview with CFO https://youtu.be/EB0HoY0NFY0 – June 4th & 9th Stockbox Research Talks June 1st | June 8th | June 15th | June 22nd & June 29th #REE #ZOO #BTC #TRU #GROC #TRI #GCAT #TIME #SBAR #BGD #RFX #PMI #PALM #MANO #BTC #HREE #ELEG #BUCE #KDNC #GSCU #MOS + RNS from #HVO #ELEG Read: https://mailchi.mp/branduk/novus-communications-june-2025-monthly-highlights-newsletter?e=036f7976ba
Continue readinghVIVO recruited participants and performed the virology and immunology laboratory services for the study hVIVO plc (AIM: HVO), a full-service Contract Research Organisation (CRO) and the world leader in human challenge clinical trials, congratulates Cidara Therapeutics (Cidara: Nasdaq CDTX) on the positive topline results from their Phase 2bfield study, for which hVIVO recruited participants and performed the virology and immunology laboratory services. The study was to determine the efficacy of Cidara’s drug-Fc conjugate, CD388, which is…
Continue readinghVIVO plc (AIM: HVO), a full-service Contract Research Organisation (CRO) and the world leader in human challenge clinical trials, announces that further to its announcement on 12 May 2025, the Company has appointed Tracey James as Independent Non-Executive Director from 1 June 2025. Tracey will be Chair of the Audit Committee, and a member of the Remuneration and Nominations Committees. Tracey is a Chartered Accountant with 26 years’ experience working at Grant Thornton UK LLP…
Continue readingOn this week’s Stockbox podcast with Alan Green, Mark Fairbairn and Dan Flynn, we discuss: Guardian Metal Resources #GMET Sealand Capital Galaxy #SCGL Sovereign Metals #SVML Katoro Gold #KAT hVIVO #HVO
Continue readinghVIVO plc (AIM: HVO), a fast-growing specialist contract research organisation (CRO) and world leader in testing infectious and respiratory disease products using human challenge clinical trials, announces that it has signed a contract with Inhalon Biopharma, Inc. (“Inhalon”), a clinical-stage company advancing a first-in-class inhaled antibody platform for treating acute respiratory infections, to assess its inhaled IN-002 antiviral candidate (“IN-002”) using the hVIVO Respiratory Syncytial Virus (RSV) Human Challenge Model. The Phase 2a randomised, double-blinded…
Continue reading
